Global Drug Delivery Devices Market Size, Share, and Industry Analysis – by Product Type, by Application, and by End-use – Growth and Trend Forecast, 2026 -2035

The drug delivery devices market size was estimated to be worth USD 440.2 billion in 2025. The market is expected to expand at a compound annual growth rate (CAGR) of 7.9% from USD 469.1 billion in 2026 to USD 926.7 billion by 2035. The strong market growth is driven by rising prevalence of chronic diseases, growing need for patient-friendly drug delivery methods, and innovations in inhalation and injection technologies. Additionally, the shift to biologics, personalized medicine, and smart connected delivery devices is further accelerating market growth globally.

Published: February 28, 2026
100 Pages

Market Overview

The drug delivery devices market has experienced robust historical growth over the past decade, driven by rising healthcare expenditure, technological improvements in device engineering, and increasing demand for minimally invasive delivery methods. Leading manufacturers have launched advanced inhalers, wearable injectors, and auto-injection systems that allow for safer self-administration. According to a 2025 article published in Biomedical Materials & Devices, advancements in wearable drug delivery device technologies are accelerating patient-friendly self-administration approaches.

The anticipated growth of the drug delivery devices market is fueled by rising prevalence of diabetes and respiratory conditions, growing geriatric population, and rapid development of innovative delivery technologies such as microneedle patches, drug-eluting implants, and connected inhalers. The growing adoption of smart drug delivery systems and home-based treatment devices is further enhancing patient convenience and medication adherence. According to recent industry reports, the market is projected to grow significantly through 2035, driven by expanding demand for patient-centric care, technological integration, and increasing healthcare access in emerging economies.

Drug Delivery Devices Market Overview

Base Year Market Size (2025): USD 440.2 Billion

CAGR: 7.9%

Forecast Year Market Size (2035): USD 926.7 Billion

Leading Region: North America

Emerging Countries: China, India, Brazil, Saudi Arabia, South Korea

Major Players:

· BD (Becton, Dickinson and Company)

· Medtronic

· Johnson & Johnson

· Novo Nordisk

· West Pharmaceutical Services

Drug Delivery Devices Market Trends

The global drug delivery devices market is undergoing a significant transformation, driven by the rapid shift toward patient-centric healthcare, biologics expansion, and advanced delivery technologies

  • The rising use of wearable injectors, smart inhalers, and auto-injection systems is streamlining drug delivery by enabling safer self-administration, improved dosing accuracy, and enhanced treatment convenience for chronic disease patients.

  • This technological shift not only enhances clinical outcomes and patient compliance but also reduces hospital dependency, making contemporary drug delivery solutions more accessible across home care and outpatient settings globally.

  • Additionally, continuous improvements in controlled-release systems, microneedle patches, and implantable drug delivery technologies are transforming therapy management by facilitating long-lasting treatments and reducing the need for invasive procedures. Manufacturers are progressively investing in advanced materials and device design to enhance comfort, safety, and drug compatibility.

  • Moreover, the growing integration of connected drug delivery devices with digital health platforms is transforming market dynamics. Smart pens, app-enabled inhalers, and remote monitoring solutions are allowing real-time adherence tracking and personalized therapy adjustments, particularly for diabetes and respiratory care.

  • This digital-first transformation is increasing patient access, supporting precision medicine approaches, and enhancing long-term disease management while reducing the overall healthcare burden.

Collectively, these advancements are expected to significantly propel market growth, foster innovation, and strengthen the global footprint of the drug delivery devices industry in the coming years.

Drug Delivery Devices Market Analysis

By Product Type

Inhalation drug delivery devices dominate with rising respiratory disease burden and widespread adoption of advanced inhalers

Based on product type, the global drug delivery devices market is segmented into oral drug delivery devices, injectable drug delivery devices, inhalation drug delivery devices, transdermal drug delivery devices, nasal drug delivery devices, ocular drug delivery devices, and implantable drug delivery devices. The inhalation drug delivery devices segment led the market, with a market share of 17.26% in 2025.

By Application

Diabetes emerges as the most dominating application segment supported by growing insulin demand and self-administration trends

Based on application, the drug delivery devices market is segmented into oncology, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and others. The diabetes segment dominated the market, with a significant market share in 2025.

By End-use

Hospitals dominate the market with strong demand for safe, high-volume drug administration and critical care delivery systems

Based on end-use, the drug delivery devices market is segmented into hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The hospitals segment led the market, with a major market share in 2025.

Regional Analysis

North America leads the global drug delivery devices market with strong innovation in self-administration and advanced healthcare infrastructure

North America held the largest share of 34.90% in the global drug delivery devices market.

Asia-Pacific on the rise as the next growth frontier for the global drug delivery devices market

The Asia-Pacific region is poised to register significant growth driven by expanding healthcare access, rising diabetic and respiratory patient populations, and increasing demand for affordable self-administration devices.

Key Companies Profiled

The competitive landscape of the global drug delivery devices market is characterized by strong competition among established manufacturers and emerging innovators. Key players such as BD, Medtronic, Novo Nordisk, and West Pharmaceutical Services collectively hold a major share of the global market, supported by their advanced injectable platforms and continuous device innovation. Meanwhile, other companies are expanding through strategic collaborations, wearable delivery solutions, and integration of connected healthcare technologies.

The market is also witnessing the emergence of regional manufacturers offering cost-effective inhalation, transdermal, and injectable drug delivery devices. Additionally, increasing investments in smart injectors, digital inhalers, biologics-compatible packaging, and patient-centric home care delivery systems are intensifying competition, pushing companies to enhance safety, improve adherence, and support next-generation therapies.

Drug Delivery Devices Market Companies:

Several prominent players driving innovation and growth in the drug delivery devices industry are as follows:

  • AptarGroup

  • Baxter International

  • BD (Becton, Dickinson and Company)

  • Catalent

  • Gerresheimer AG

  • GSK (GlaxoSmithKline)

  • Insulet Corporation

  • Johnson & Johnson

  • Medtronic

  • Nemera

  • Novartis

  • Novo Nordisk

  • Owen Mumford

  • Pfizer

  • Phillips-Medisize (Molex)

  • Roche

  • Sanofi

  • SHL Medical

  • West Pharmaceutical Services

Market Segmentation

This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the drug delivery devices market by-

Product Type (Revenue in USD Million, 2021 - 2035)

o Oral Drug Delivery Devices

  • Controlled-release Tablets and Capsules

  • Buccal and Sublingual Tablets Camera Systems

o Injectable Drug Delivery Devices

  • Prefilled Syringes

  • Auto-injectors

  • Pen injectors

  • Needle-free Injectors

  • Wearable Injectors

o Inhalation Drug Delivery Devices

  • Metered Dose Inhalers

  • Dry Powder Inhalers

  • Soft Mist Inhalers

  • Nebulizers

o Transdermal Drug Delivery Devices

  • Transdermal Patches

  • Iontophoresis Devices

  • Microneedle Patches

o Nasal Drug Delivery Devices

  • Nasal Spray Pumps

  • Nasal Drops

  • Nasal Powder Devices

o Ocular Drug Delivery Devices

  • Eye Drop Dispensers

  • Ocular Inserts

  • Drug-eluting Contact Lenses

o Implantable Drug Delivery Devices

  • Drug-eluting Implants

  • Infusion Pumps

  • Biodegradable Implants

Application (Revenue in USD Million, 2021 - 2035)

o Oncology

o Infectious Diseases

o Respiratory Diseases

o Diabetes

o Cardiovascular Diseases

o Autoimmune Diseases

o Central Nervous System Disorders

o Others

End-use (Revenue in USD Million, 2021 - 2035)

o Hospitals

o Diagnostic Centers

o Ambulatory Surgery Centers/Clinics

o Home Care Settings

o Others

Regional (Revenue in USD Million, 2021 - 2035)

North America

  • U.S.

  • Canada

Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

  • Switzerland

  • Netherlands

Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

  • Indonesia

Latin America

  • Brazil

  • Mexico

  • Argentina

  • Colombia

Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Consumer Behaviour Analysis

3.5. Value Chain Analysis

3.6. Technology Roadmap

3.7. Porters Analysis

3.8. PESTLE Analysis

4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)

4.1. Oral Drug Delivery Devices

4.1.1. Controlled-release Tablets and Capsules

4.1.2. Buccal and Sublingual Tablets Camera Systems

4.2. Injectable Drug Delivery Devices

4.2.1. Prefilled Syringes

4.2.2. Auto-injectors

4.2.3. Pen injectors

4.2.4. Needle-free Injectors

4.2.5. Wearable Injectors

4.3. Inhalation Drug Delivery Devices

4.3.1. Metered Dose Inhalers

4.3.2. Dry Powder Inhalers

4.3.3. Soft Mist Inhalers

4.3.4. Nebulizers

4.4. Transdermal Drug Delivery Devices

4.4.1. Transdermal Patches

4.4.2. Iontophoresis Devices

4.4.3. Microneedle Patches

4.5. Nasal Drug Delivery Devices

4.5.1. Nasal Spray Pumps

4.5.2. Nasal Drops

4.5.3. Nasal Powder Devices

4.6. Ocular Drug Delivery Devices

4.6.1. Eye Drop Dispensers

4.6.2. Ocular Inserts

4.6.3. Drug-eluting Contact Lenses

4.7. Implantable Drug Delivery Devices

4.7.1. Drug-eluting Implants

4.7.2. Infusion Pumps

4.7.3. Biodegradable Implants

5. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)

5.1. Oncology

5.2. Infectious Diseases

5.3. Respiratory Diseases

5.4. Diabetes

5.5. Cardiovascular Diseases

5.6. Autoimmune Diseases

5.7. Central Nervous System Disorders

5.8. Others

6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)

6.1. Hospitals

6.2. Diagnostic Centers

6.3. Ambulatory Surgery Centers/Clinics

6.4. Home Care Settings

6.5. Others

7. Market Estimates and Forecasts, By Region, 2021 - 2035 (USD Mn)

7.1. North America

7.1.1. U.S.

7.1.1.1. U.S. Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.1.1.2. Market Dynamics

7.1.1.3. Competitive Landscape

7.1.1.4. Regulatory Framework

7.1.1.5. Reimbursement Scenario

7.1.2. Canada

7.1.2.1. Canada Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.1.2.2. Market Dynamics

7.1.2.3. Competitive Landscape

7.1.2.4. Regulatory Framework

7.1.2.5. Reimbursement Scenario

7.2. Europe

7.2.1. Germany

7.2.1.1. Germany Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.1.2. Market Dynamics

7.2.1.3. Competitive Landscape

7.2.1.4. Regulatory Framework

7.2.1.5. Reimbursement Scenario

7.2.2. U.K.

7.2.2.1. UK Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.2.2. Market Dynamics

7.2.2.3. Competitive Landscape

7.2.2.4. Regulatory Framework

7.2.2.5. Reimbursement Scenario

7.2.3. France

7.2.3.1. France Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.3.2. Market Dynamics

7.2.3.3. Competitive Landscape

7.2.3.4. Regulatory Framework

7.2.3.5. Reimbursement Scenario

7.2.4. Italy

7.2.4.1. Italy Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.4.2. Market Dynamics

7.2.4.3. Competitive Landscape

7.2.4.4. Regulatory Framework

7.2.4.5. Reimbursement Scenario

7.2.5. Spain

7.2.5.1. Spain Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.5.2. Market Dynamics

7.2.5.3. Competitive Landscape

7.2.5.4. Regulatory Framework

7.2.5.5. Reimbursement Scenario

7.2.6. Sweden

7.2.6.1. Sweden Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.6.2. Market Dynamics

7.2.6.3. Competitive Landscape

7.2.6.4. Regulatory Framework

7.2.6.5. Reimbursement Scenario

7.2.7. Norway

7.2.7.1. Norway Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.7.2. Market Dynamics

7.2.7.3. Competitive Landscape

7.2.7.4. Regulatory Framework

7.2.7.5. Reimbursement Scenario

7.2.8. Denmark

7.2.8.1. Denmark Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.8.2. Market Dynamics

7.2.8.3. Competitive Landscape

7.2.8.4. Regulatory Framework

7.2.8.5. Reimbursement Scenario

7.2.9. Switzerland

7.2.9.1. Switzerland Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.9.2. Market Dynamics

7.2.9.3. Competitive Landscape

7.2.9.4. Regulatory Framework

7.2.9.5. Reimbursement Scenario

7.2.10. Netherlands

7.2.10.1. Netherlands Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.10.2. Market Dynamics

7.2.10.3. Competitive Landscape

7.2.10.4. Regulatory Framework

7.2.10.5. Reimbursement Scenario

7.2.11. Rest of Europe

7.2.11.1. Rest of Europe Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.11.2. Market Dynamics

7.2.11.3. Competitive Landscape

7.2.11.4. Regulatory Framework

7.2.11.5. Reimbursement Scenario

7.3. Asia Pacific

7.3.1. China

7.3.1.1. China Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.1.2. Market Dynamics

7.3.1.3. Competitive Landscape

7.3.1.4. Regulatory Framework

7.3.1.5. Reimbursement Scenario

7.3.2. Japan

7.3.2.1. Japan Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.2.2. Market Dynamics

7.3.2.3. Competitive Landscape

7.3.2.4. Regulatory Framework

7.3.2.5. Reimbursement Scenario

7.3.3. India

7.3.3.1. India Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.3.2. Market Dynamics

7.3.3.3. Competitive Landscape

7.3.3.4. Regulatory Framework

7.3.3.5. Reimbursement Scenario

7.3.4. Australia

7.3.4.1. Australia Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.4.2. Market Dynamics

7.3.4.3. Competitive Landscape

7.3.4.4. Regulatory Framework

7.3.4.5. Reimbursement Scenario

7.3.5. South Korea

7.3.5.1. South Korea Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.5.2. Market Dynamics

7.3.5.3. Competitive Landscape

7.3.5.4. Regulatory Framework

7.3.5.5. Reimbursement Scenario

7.3.6. Thailand

7.3.6.1. Thailand Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.6.2. Market Dynamics

7.3.6.3. Competitive Landscape

7.3.6.4. Regulatory Framework

7.3.6.5. Reimbursement Scenario

7.3.7. Indonesia

7.3.7.1. Indonesia Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.7.2. Market Dynamics

7.3.7.3. Competitive Landscape

7.3.7.4. Regulatory Framework

7.3.7.5. Reimbursement Scenario

7.3.8. Rest of Asia Pacific

7.3.8.1. Rest of Asia Pacific Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.8.2. Market Dynamics

7.3.8.3. Competitive Landscape

7.3.8.4. Regulatory Framework

7.3.8.5. Reimbursement Scenario

7.4. Latin America

7.4.1. Brazil

7.4.1.1. Brazil Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.1.2. Market Dynamics

7.4.1.3. Competitive Landscape

7.4.1.4. Regulatory Framework

7.4.1.5. Reimbursement Scenario

7.4.2. Mexico

7.4.2.1. Mexico Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.2.2. Market Dynamics

7.4.2.3. Competitive Landscape

7.4.2.4. Regulatory Framework

7.4.2.5. Reimbursement Scenario

7.4.3. Argentina

7.4.3.1. Argentina Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.3.2. Market Dynamics

7.4.3.3. Competitive Landscape

7.4.3.4. Regulatory Framework

7.4.3.5. Reimbursement Scenario

7.4.4. Colombia

7.4.4.1. Colombia Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.4.2. Market Dynamics

7.4.4.3. Competitive Landscape

7.4.4.4. Regulatory Framework

7.4.4.5. Reimbursement Scenario

7.5. Middle East and Africa

7.5.1. South Africa

7.5.1.1. South Africa Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.1.2. Market Dynamics

7.5.1.3. Competitive Landscape

7.5.1.4. Regulatory Framework

7.5.1.5. Reimbursement Scenario

7.5.2. Saudi Arabia

7.5.2.1. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.2.2. Market Dynamics

7.5.2.3. Competitive Landscape

7.5.2.4. Regulatory Framework

7.5.2.5. Reimbursement Scenario

7.5.3. UAE

7.5.3.1. UAE Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.3.2. Market Dynamics

7.5.3.3. Competitive Landscape

7.5.3.4. Regulatory Framework

7.5.3.5. Reimbursement Scenario

7.5.4. Kuwait

7.5.4.1. Kuwait Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.4.2. Market Dynamics

7.5.4.3. Competitive Landscape

7.5.4.4. Regulatory Framework

7.5.4.5. Reimbursement Scenario

7.5.5. Rest of Middle East and Africa

7.5.5.1. Rest of MEA Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.5.2. Market Dynamics

7.5.5.3. Competitive Landscape

7.5.5.4. Regulatory Framework

7.5.5.5. Reimbursement Scenario

8. Competitive Landscape

8.1. Company Market Share Analysis, 2025

8.2. Company Tier Structure

8.3. List of Major Suppliers, By Key Countries

8.4. Key Company Positioning Analysis

8.5. Company Profile

8.5.1. AptarGroup

8.5.2. Baxter International

8.5.3. BD (Becton, Dickinson and Company)

8.5.4. Catalent

8.5.5. Gerresheimer AG

8.5.6. GSK (GlaxoSmithKline)

8.5.7. Insulet Corporation

8.5.8. Johnson & Johnson

8.5.9. Medtronic

8.5.10. Nemera

8.5.11. Novartis

8.5.12. Novo Nordisk

8.5.13. Owen Mumford

8.5.14. Pfizer

8.5.15. Phillips-Medisize (Molex)

8.5.16. Roche

8.5.17. Sanofi

8.5.18. SHL Medical

8.5.19. West Pharmaceutical Services

8.6. Key Development Strategies

8.6.1. New Product Launches

8.6.2. Mergers and Acquisition

8.6.3. Partnerships and Collaborations

8.6.4. Expansion Plans

9. Analyst Perspective

10. Related Reports

Related Research

Global Urinary Catheters Market Size, Share, and Industry Analysis – by Product Type, by Material Type, by Coating, by Application, by Gender, and by End-use- Growth and Trend Forecast, 2026- 2035

April 3, 2026View

Global Nasal Cannula Market Size, Share, and Industry Analysis – by Product Type, by Material Type, and by End-use – Growth and Trend Forecast, 2026- 2035

April 2, 2026View

Global Midline Catheter Market Size, Share, and Industry Analysis – by Design Type, by Material Type, by Application, and by End-use- Growth and Trend Forecast, 2026- 2035

April 2, 2026View

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.